Crossmark

Optimal time of starting tocilizumab in acute phase of adult-onset Still’s disease and comparison of its efficacy with that of methotrexate: a case series and a review of the literature

Crossref DOI link: https://doi.org/10.1007/s10067-024-06905-8

Published Online: 2024-02-12

Published Print: 2024-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Suzuki, Satoshi http://orcid.org/0000-0002-8172-2413
Kataoka, Yuko

Otani, Tomoya

Taniguchi, Yukino

Ikeda, Keigo

Tamura, Naoto

Morimoto, Shinji
License Information

Text and Data Mining valid from 2024-02-12

Version of Record valid from 2024-02-12
More Information

Article History

Received: 18 January 2024

Revised: 18 January 2024

Accepted: 3 February 2024

First Online: 12 February 2024

Declarations

:

: This study was conducted in accordance with the principles of the Declaration of Helsinki. Informed consent was obtained in an opt-out manner via the institute’s website, in accordance with the guidelines of the Ethics Committee of Juntendo University (no. E23-0219).

: None.

Document is current

Any future updates will be listed below